#Dexamethasone

Rajeev Venkayya MD

rvenkayya

I've participated in some great discussions on #COVID19 and #vaccines on #Clubhouse recently. I’ll use this thread to share some references I’ve mentioned and/or plan to bring up in future

Eric Topol

EricTopol

The impressive reduction of mortality achieved during the pandemic for patients admitted to the ICUFrom UK @ICNARC @CebmOxford data https://www.economist.com/science-and-technology/2020/08/22/when-covid-19-becomes-a-chronic-illness The 10 t

Francisco Marty, MD

FranciscoMarty_

With the .@NIAIDNews #ACCT1 trial final report published on 05 Nov 2020 and the .@WHO's #SolidarityTrial Preliminary report published on 02 December 2020, thought it would be good to take

Megan Ranney MD MPH 🗽

meganranney

A short smattering of the research I'm following this week re #COVID19, and why my editorial take on why these matter: 1. Not surprisingly, but quite relevant to those of

Andy Conway Morris 😷🧼🇬🇧🇪🇺

andymoz78

So the #RECOVERYtrial RECOVERY dexamethasone study has been released as a preprint, although one should be careful of pre-prints, the team delivering this & the nature of the (non-commercial) study

Chris Jones

ChrisJ999

Time to clarify some things on paramedic drugs. 1) @JRCALCguidance is not a set of PGDs. It's just guidance. 2) If you want proper guidlines on drug administration, not abbreviated

Dominique Tomacruz, MD

DTomacruzMD

Read a compelling article published a few days ago entitled: Haemoperfusion should only be used for COVID-19 in the context of randomized trials by @hswapnil @DrRonWald et al https://www.nature.com/articles/s41581-020-00352-9Some key

Anupam Singh

anupampom

While Favipravir and Coronil Trial are being criticized for lack of Blinding and gaining approval via Press Release. Have major drug trials done better?1. RECOVERY. Open label(No blinding). Evidence dexamethasone

Matt McCarthy

DrMattMcCarthy

Here are 3 #COVID19 questions we're trying to answer:1. Why do monoclonal antibodies fail hospitalized patients? Cocktails made by Eli Lilly & Regeneron may be useful for high-risk outpatients, but

Ms Understood

pleased2bme

The reason COVID19 is so deadly is because our immune system has never seen it before. 8% of true human genome consists of viruses contracted by our ancestors which is

Dr. Nahid Bhadelia

BhadeliaMD

My thoughts on RECOVERY trial results (not data). First, here is the methodology & results.-Large (11k) trial testing multiple treatment arms-2104 randomised to dexamethasone 6mg/d for ten days and compared

Pattern Integrity Films

pttrn_ntgrty

We're not going to make anymore films on the matter, all of these in this thread should have easily been enough...#InvokeThe25th1/https://twitter.com/RBReich/status/1341421160085352448 Exhibit A:#The25thFor45He should have been removed

Francisco Marty, MD

FranciscoMarty_

It took a while to digest the details of over 600 pages, but here is my review and comparative analysis of the #ACTT2 trial that compared #baricitinib vs. #placebo among

Martin Landray

MartinLandray

RECOVERY Update:30,000 patients now enrolled in one country in 10 months.The most extraordinary effort.And still ongoing. In the words of the independent Data Monitoring Committee:"Thank you for your continuing help

Bloomberg Opinion

bopinion

When the discussion turns to which countries have responded best to Covid-19, those most often mentioned are:TaiwanNew ZealandVietnam@tylercowen would like to make a more surprising nomination: the U.K.https://trib.al/ACGcNds At first

Eugene Gu, MD

eugenegu

I’ve warned about this many times, but it always fell on deaf ears as everyone likes rushing things through clinical trials and doing emergency authorizations at warp speed. Convalescent plasma

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.